# Nebula Gene

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nebula-gene

- Industry: Biotechnology
- Headquarters: Harbin, China
- Latest round: Series A (Sep 13, 2016)
- Investors on record: 4

## About

Established in 2014 and based in Harbin, China, Nebula Gene is a medical company that provides genetic testing, genomic data analysis and relevant services. In April 2015, the company closed an angel funding from new investor Harbin Institute of Technology Assets Investment Management. In September 2016, it closed a series A funding from new investors Shenzhen Guozhong Venture Capital Management, Shenzhen Capital Group, Lanma Capital Management and Harbin Kaizhi Chenfeng Investment Management. 

Nebula Gene mainly provides scientific and technological services based on next-generation sequencing, medical testing services, personal genome health services, and healthcare information system construction services. Based on its self-developed personal genome management and analysis system, the company can provide customers with medical testing, medication guidance, individualized healthcare testing services, and scientific and technological services for researchers. Its services include services such as analysis of genomic data in family lines and genetic testing for hereditary breast and ovarian cancer.

## Funding rounds

- Series A, Sep 13, 2016 — Shenzhen Guozhong Venture Capital, Shenzhen Capital Real Estate Fund, Kaizhi Chenfeng Investment Management, Landmark Capital

## Investors

- Shenzhen Guozhong Venture Capital (https://capitalatlas.ai/funds/shenzhen-guozhong-venture-capital) — Series A
- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Series A
- Kaizhi Chenfeng Investment Management (https://capitalatlas.ai/funds/kaizhi-chenfeng-investment-management) — Series A
- Landmark Capital (https://capitalatlas.ai/funds/landmark-capital) — Series A